DekaBank Deutsche Girozentrale’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-27,000
Closed -$935K 1195
2014
Q4
$935K Sell
27,000
-2,500
-8% -$81.5K 0.01% 572
2014
Q3
$881K Buy
29,500
+700
+2% +$14.8K 0.01% 537
2014
Q2
$578K Sell
28,800
-1,500
-5% -$34.4K 0.01% 583
2014
Q1
$824K Buy
30,300
+2,200
+8% +$58.4K 0.01% 504
2013
Q4
$581K Buy
28,100
+600
+2% +$11.3K 0.01% 529
2013
Q3
$501K Buy
+27,500
New +$497K 0.01% 548

Other funds holding AUXL

DekaBank Deutsche Girozentrale's AUXL Position: Q1 2015 in Review

DekaBank Deutsche Girozentrale sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 27,000 shares — an estimated $935K sold.

DekaBank Deutsche Girozentrale first reported a position in AUXL in Q3 2013 and held it in 6 quarters. The position peaked at $935K in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • DekaBank Deutsche Girozentrale reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 27,000 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $935K.
  • DekaBank Deutsche Girozentrale first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q3 2013 and held it in 6 quarters.
  • DekaBank Deutsche Girozentrale's AUXILIUM PHARAMCEUTICALS INC position peaked at $935K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2015, filed 5 May 2015.